Exact Sciences
EXAS
#1175
Rank
ยฃ14.85 B
Marketcap
ยฃ77.81
Share price
0.00%
Change (1 day)
116.53%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Earnings for Exact Sciences (EXAS)

Earnings in 2025 (TTM): -ยฃ0.14 Billion

According to Exact Sciences's latest financial reports the company's current earnings are ยฃ3.24 Billion. , an increase over its 2024 earnings that were of -ยฃ0.76 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Exact Sciences from 2001 to 2025

Annual earnings

Year Earnings Change
2025 -ยฃ0.14 Billion-82.05%
2024 -ยฃ0.76 Billion435.05%
2023 -ยฃ0.15 Billion-69.18%
2022 -ยฃ0.46 Billion-25.77%
2021 -ยฃ0.62 Billion1.68%
2020 -ยฃ0.61 Billion271.17%
2019 -ยฃ0.17 Billion58.99%
2018 -ยฃ0.11 Billion20.89%
2017 -ยฃ84.84 Million-30.95%
2016 -ยฃ0.13 Billion5.09%
2015 -ยฃ0.12 Billion57.24%
2014 -ยฃ74.36 Million116.53%
2013 -ยฃ34.34 Million
2011 -ยฃ21.38 Million143.73%
2010 -ยฃ8.78 Million27.85%
2009 -ยฃ6.87 Million0.27%
2008 -ยฃ6.85 Million-20.95%
2007 -ยฃ8.66 Million-13.53%
2006 -ยฃ10.02 Million-10.07%
2005 -ยฃ11.14 Million-21.81%
2004 -ยฃ14.24 Million-33.44%
2003 -ยฃ21.4 Million-6.51%
2002 -ยฃ22.88 Million17.95%
2001 -ยฃ19.4 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Sanofi
SNY
ยฃ5.68 B-4,302.85%๐Ÿ‡ซ๐Ÿ‡ท France
Veracyte
VCYT
ยฃ67.3 M-149.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Antares Pharma
ATRS
ยฃ48.86 M-136.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
-ยฃ0.29 Billion 111.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
-ยฃ25.94 Million-80.81%๐Ÿ‡บ๐Ÿ‡ธ USA